Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
430 INR | +1.24% | +2.83% | +19.05% |
29/05 | Solara Active Pharma Sciences Limited Re-Affirms Earnings Guidance for the Fiscal Year 2025 | CI |
29/05 | Transcript : Solara Active Pharma Sciences Limited, Q4 2024 Earnings Call, May 29, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.05% | 244M | |
+43.64% | 754B | |
+39.95% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.95% | 217B | |
-1.23% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Transcript : Solara Active Pharma Sciences Limited, Q2 2022 Earnings Call, Nov 11, 2021